Synthesis of purinyl homo-carbonucleoside derivatives of 2-benzylcyclopenta[c]pyrazol

Synthesis

Volumn , Issue 6, 2005, Pages 925-932

  García, Marcos D ^a   Caamaño, Olga ^a   Fernández, Franco ^a   López, Carmen ^a   De Clercq, Erick ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral activity; Benzylcyclopenta c pyrazol; Glycol cleavage; Methanoindazoles; Purinyl carbonucleosides

Indexed keywords

ALCOHOLS; ALDEHYDES; BENZENE; COMPLEXATION; CYTOLOGY; OXIDATION; REACTION KINETICS; REDUCTION; TOXICITY; VIRUSES;

CYTOMAGALOVIRUS; DIALDEHYDES; MESYLATION; REACTION SEQUENCES;

SYNTHESIS (CHEMICAL);

4 [(2 AMINO 6 CHLORO 9H PURIN 9 YL)METHYL] 2 BENZYL 6 TERT BUTYLDIPHENYLSILYLOXYMETHYLCYCLOPENTA[C]PYRAZOLE; 4 [(6 AMINO 9H PURIN 9 YL)METHYL] 2 BENZYL 6 TERT BUTYLDIPHENYLSILYLOXYMETHYLCYCLOPENTA[C]PYRAZOLE; CYCLOPENTANE DERIVATIVE; INDAZOLE DERIVATIVE; METHANOL; NUCLEOSIDE DERIVATIVE; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS; DRUG STRUCTURE; DRUG SYNTHESIS; OXIDATION KINETICS; REACTION ANALYSIS; REDUCTION; STRUCTURE ANALYSIS; VARICELLA ZOSTER VIRUS;

EID: 17744377004     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-861831     Document Type: Article

References (34)

1. (a) Borthwick, A. D.; Biggadike, K. Tetrahedron 1992, 48, 571.
2. (b) Agrofoglio, L.; Suhas, E.; Farese, A.; Condom, R.; Challand, S. R.; Earl, R. A.; Guedj, R. Tetrahedron 1994, 50, 10611.
3. (c) Huryn, D.; Okabe, M. Chem. Rev. 1992, 92, 1745.
4. (d) Mansour, T. S.; Storer, R. Curr. Pharm. Des. 1997, 3, 227.
5. (e) Ichikewa, E.; Kato, K. Curr. Med. Chem. 2001, 8, 385.
6. (a) Marquez, V.; Lim, M. Med. Res. Rev. 1986, 6, 1.
7. (b) Roberts, S.; Biggadike, K.; Borthwick, A. D.; Kirk, B. In Topics in Medicinal Chemistry; Leeming, P. R., Ed.; Royal Society of Chemistry: London, 1988, 172.
8. (a) Shealy, Y. F.; Clayton, J. D. J. Am. Chem. Soc. 1966, 88, 3885.
9. (b) Shealy, Y. F.; Clayton, J. D. J. Am. Chem. Soc. 1969, 91, 3075.
10. (c) Shealy, Y. F.; Clayton, J. D. J. Pharm. Sci. 1973, 62, 1432.
11. (a) Crimmins, M. T. Tetrahedron 1998, 54, 9229.
12. (b) Zhu, X. F. Nucleosides, Nucleotides Nucleic Acids 2000, 19, 297.
13. Crimmins, M. T.; King, B. W. J. Org. Chem. 1996, 61, 4192.
14. (a) Daluge, S. M.; Good, S. S.; Faletto, M. B.; Miller, W. H.; Wayne, H.; St. Clair, M. H.; Boone, L. R.; Tisdale, M.; Parry, N. R.; Reardon, J. E.; Dornsife, R. E.; Averett, D. R.; Krenitsky, T. A. Antimicrob. Agents Chemother. 1997, 41, 1082.
15. (b) Faletto, M. B.; Miller, W. H.; St. Clair, E. P.; Garvey, M. H.; Daluge, S. M.; Good, S. S. Antimicrob. Agents Chemother. 1997, 41, 1099.
16. (c) Foster, R. H.; Faulds, D. Drugs 1998, 53, 729.
17. Lea A. P., Faulds D.; Drugs; 1996, 51: 846.
18. Fernández, F.; García-Mera, X.; Morales, M.; Rodríguez-Borges, J. E. Synthesis 2001, 239.
19. Fernández, F.; García-Mera, X.; Morales, M.; Rodríguez-Borges, J. E.; De Clercq, E. Synthesis 2002, 1084.
20. López, C.; Caamaño, O.; Hergueta, A. R.; Fernández, F.; García, M. D. Tetrahedron Lett. 2002, 43, 5311.
21. García, M. D.; Caamaño, O.; Fernández, F.; Figueira, M. J.; Gómez, G. Synthesis 2003, 2138.
22. (a) Mitsunobu, O. Synthesis 1981, 1.
23. (b) Hughes, D. L. In Organic Reactions, Vol. 42; Paquette, L. A., Ed.; John Wiley and Sons: New York, 1992, 344.
24. 11
25. (a) Elguero, J.; Marzin, C.; Katritzky, A. R.; Linda, P. The Tautomerism of Heterocycles; Academic Press: New York, 1976, 29.
26. (b) Elguero, J.; Marzin, C.; Katritzky, A. R.; Linda, P. The Tautomerism of Heterocycles; Academic Press: New York, 1976, 266.
27. (c) Elguero, J.; Marzin, C.; Katritzky, A. R.; Linda, P. The Tautomerism of Heterocycles; Academic Press: New York, 1976, 412.
28. Martínez, A.; Jimeno, M. L.; Elguero, J. New J. Chem. 1994, 18, 269.
29. Kotsuki, H.; Wakao, M.; Hayakawa, H.; Shimanouchi, T.; Shiro, M. J. Org. Chem. 1996, 61, 8915.
30. The crystallographic data of 10 and 18 have been deposited at the Cambridge Crystallographic Data Centre as Supplementary Publications CCDC 240518 and CCDC 240519 respectively. Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK.
31. Hossain, N.; Blaton, N.; Peeters, O.; Rozenski, J.; Herdewijn, P. A. Tetrahedron 1996, 52, 5563.
32. (a) De Clercq, E. In In vitro and ex vitro test systems to rationalize drug design and delivery; Symposium organized by Association de Pharmacie Galénique Industrielle (AGPI) and International Pharmaceutical Federation (FIP): Paris, 13 and 14 December 1993.
33. (b) Crommelin, D.; Couvreur, P.; Duchêne, D. Editions de Santé: Paris, France 1994, 108.
34. Saksena, A. K.; McPhail, A. T.; Onan, K. D. Tetrahedron Lett. 1981, 22, 2067.